Condition
Pelvis Pain Chronic
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 54/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
50%
2 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results67% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 4 (2)
Trial Status
Completed2
Terminated1
Withdrawn1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT01451606Phase 4TerminatedPrimary
Duloxetine for the Treatment of Chronic Pelvic Pain
NCT02356796Not ApplicableCompletedPrimary
Chronic Pelvic Pain in Women - Conservative Group Treatment Compared to Standard Conservative Treatment.
NCT02160483Not ApplicableWithdrawnPrimary
Functional Brain Imaging and Psychological Testing in Women With Chronic Pelvic Pain
NCT01635205Phase 4Completed
Paraspinous Anesthetic Block for Non-Responsive Pelvic Pain
Showing all 4 trials